Methyl 4-(butylcarbaMoyl)benzoate
|
- $55 - $497.17
- Product name: Methyl 4-(butylcarbaMoyl)benzoate
- CAS: 100610-03-5
- MF: C13H17NO3
- MW: 235.28
- EINECS:
- MDL Number:MFCD09418666
- Synonyms:Methyl 4-(butylcarbaMoyl)benzoate;Benzoic acid, 4-[(butylamino)carbonyl]-, methyl ester
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- TRC
Package
- 5MG
- 250mg
- 1g
- 25g
- ManufacturerAK Scientific
- Product number0234AA
- Product descriptionMethyl4-(butylcarbamoyl)benzoate
- Packaging1g
- Price$131
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0393158
- Product descriptionMETHYL-4-(BUTYLCARBAMOYL)BENZOATE 95.00%
- Packaging5MG
- Price$497.17
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12188062
- Product descriptionMethyl4-(butylcarbamoyl)benzoate 95+%
- Packaging25g
- Price$452
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM296383
- Product descriptionMethyl4-(butylcarbamoyl)benzoate
- Packaging250mg
- Price$55
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 0234AA | Methyl4-(butylcarbamoyl)benzoate | 1g | $131 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0393158 | METHYL-4-(BUTYLCARBAMOYL)BENZOATE 95.00% | 5MG | $497.17 | 2021-12-16 | Buy |
| Crysdot | CD12188062 | Methyl4-(butylcarbamoyl)benzoate 95+% | 25g | $452 | 2021-12-16 | Buy |
| TRC | M296383 | Methyl4-(butylcarbamoyl)benzoate | 250mg | $55 | 2021-12-16 | Buy |
Properties
Melting point :121 °C
Boiling point :393.9±25.0 °C(Predicted)
Density :1.083±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :14.32±0.46(Predicted)
Boiling point :393.9±25.0 °C(Predicted)
Density :1.083±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :14.32±0.46(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|